Stepan Company

Stepan Company

SCL
Stepan CompanyUS flagNew York Stock Exchange
51.68
USD
-0.72
- -
1.17BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
83.14
84.68
78.14
77.49
83.89
86.61
80.63
81.47
102.35
121.74
102.11
95.49
101.96
102.44
Basic EPS, GAAP
3.22
2.51
3.34
3.78
4.39
4.83
4.47
5.52
6.01
6.46
1.77
2.21
2.05
-0.62
Free Cash Flow per Basic Share
2.54
-0.84
2.83
4.79
5.24
3.67
4.9
4.77
3.15
7.06
7.68
7.1
6.47
6.9
Dividend per Share
0.64
0.68
0.72
0.76
0.82
0.91
1
1.11
1.23
1.34
1.44
1.49
1.53
1.54
Book Value per Share
22.3
24
26.66
29.61
32.59
37.5
41.16
45.77
50.62
56.05
56.39
56.98
57.41
55.2
Tangible Book Value per Share
22.91
22.17
23.28
25.81
30.39
33.49
36.92
40.8
39.97
44.43
46.82
45.37
48.61
46.47
Basic Weighted Avg Shares
23
23
23
23
23
23
23
23
23
23
23
23
23
23
Sales/Revenue/Turnover
1,881
1,927
1,776
1,766
1,925
1,994
1,859
1,870
2,346
2,773
2,326
2,180
2,332
2,343
Operating Margin (%)
5.86
4.91
6.75
7.64
8.2
7.62
6.96
9.22
7.45
7.51
3.14
3.25
2.98
2.43
Depreciation Expense
56
64
67
75
79
81
79
82
91
95
105
112
126
130
Net Income, GAAP
73
57
76
86
101
111
103
127
138
147
40
50
47
-14
Effective Tax Rate (%)
24.36
24.43
26.07
24.27
31.41
19.35
18.11
25.38
20.08
22.02
16.92
16.66
21.72
52.1
Profit Margin (%)
3.87
2.96
4.28
4.88
5.23
5.57
5.55
6.78
5.87
5.31
1.73
2.31
2.01
-0.61
Working Capital
340
326
376
388
468
495
480
489
413
374
244
141
192
186
LT Debt
235
247
313
289
268
239
228
212
380
506
459
390
390
376
Total Equity
554
537
558
636
741
808
892
988
1,074
1,166
1,216
1,170
1,244
1,193
Return on Invested Capital (%)
11.29
8.84
10.54
11.2
11.02
11.68
9.59
10.89
10.29
9.92
3.27
3.14
2.9
- -
Return on Capital (%)
11.53
8.26
9.86
10.05
10.83
11.13
9.63
10.51
9.94
8.91
2.73
3.35
3.39
5.1
Return on Common Equity (%)
15.33
10.87
13.19
13.46
14.17
13.79
11.38
12.68
12.47
12.08
3.14
3.9
3.59
-1.1

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
298
286
323
LT Borrowings
357
341
328
LT Finance Leases
52
49
47
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
23
23
23
Market Capitalization
1,091
1,083
1,143

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
929
859
906
Cash, Cash Equivalents & STI
119
133
141
Accounts Receivable, Net
436
388
434
Inventories
324
299
289
Total Current Liabilities
714
666
720
Payables & Accruals
411
381
397
ST Debt
298
286
323
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.47%
4.81%
6.33%
Free Cash Flow
16.2%
16.3%
-8.74%
Net Income, GAAP
1.76%
-7.76%
-6.9%
Sales/Revenue/Turnover
3.41%
5.65%
6.96%
Total Cash Common Dividend
7.99%
6.68%
3.18%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
551
556
547
526
2,180
2025
593
595
590
554
2,332
2026
605
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.61
0.42
1.03
0.15
2.21
2025
0.86
0.5
0.47
0.22
2.05
2026
-1.81
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.37
0.37
0.37
0.38
1.49
2025
0.38
0.38
0.38
0.39
1.53
2026
0.39
- -
- -
- -
- -

Company Description

APIChat
CEO
Luis E. Rojo
Full Time Employees
2,396
Sector
Basic Materials
Industry
Chemicals - Specialty
Address
1101 Skokie Boulevard Northbrook IL United States of America 60062
IPO Date
Mar 17, 1992
Website
stepan.com
Business
Stepan Company Stepan Company manufactures specialty and intermediate chemicals for consumer and industrial applications worldwide. Founded in 1932 and headquartered in Northbrook, Illinois, the company operates through three main segments: surfactants, polymers, and specialty products; it serves industries including household and personal care, agriculture, oilfield, construction, food and nutrition, and pharmaceuticals with manufacturing facilities across North America, Europe, Asia, and South America. Its surfactant portfolio, for which it claims status as the world's largest merchant producer of anionic surfactants, encompasses sulfonates, sulfates, phosphate esters, amphoterics, quaternaries, and nonionics used in detergents, shampoos, cleaners, crop protection formulations, fabric softeners, emulsifiers, dispersants, and tank mix adjuvants under brands such as STEPAN®, TOXIMUL®, STEPFAC™, STEPSPERSE®, STEPWET®, STEPOSOL®, STEP-FLOW®, and HALLCOMID®; the polymers segment offers polyester polyols for rigid foam insulation in construction, refrigeration, and CASE (coatings, adhesives, sealants, elastomers) applications; while specialty products include ingredients for antimicrobials, flavors, nutritional supplements, emulsion polymerization, phthalic anhydride, and pharmaceutical excipients, notably processing coca leaf extracts for beverages like Coca-Cola and supplying cocaine derivatives for medicinal use. Stepan Company maintains a broad global footprint with approximately 2,000 employees and sites supporting diverse markets from personal care foaming agents to agricultural dispersants and wetting agents, including advanced formulation services for organic farming and green solvents like methyl esters derived from soybean oil. In recent developments, the company completed the sale of its Philippine subsidiary Stepan Philippines Quaternaries Inc. (SPQI) manufacturing facility to Musim Mas's Masurf Inc. on November 14, 2025, establishing a tolling arrangement to ensure continued Southeast Asian customer service while streamlining focus on core growth assets. Earlier, Stepan boosted its alpha olefin sulfonate (AOS) production capacity by 25% through capital investments and process enhancements, and it expanded alkoxylation capabilities with a $245 million investment in Pasadena, Texas, set for early operations.

Company News

APIChat
  • Dividend Champion, Contender, And Challenger Highlights: Week Of June 7

  • Stepan Co (SCL) Stock Up 3.1% and Still Undervalued -- GF Score: 77/100

  • Stepan Company (SCL) Q1 2026 Earnings Call Transcript

  • Stepan Co. (SCL) Beats Q1 Earnings Estimates

  • Stepan Reports First Quarter 2026 Results

  • Stepan Declares Quarterly Dividend

  • Earnings Preview: Stepan Co. (SCL) Q1 Earnings Expected to Decline

  • Stepan to Announce First Quarter 2026 Results on April 28, 2026

  • SG Americas Securities LLC Boosts Stake in Stepan Company $SCL

  • Stepan Company: The Ride Higher Isn't Over Yet

  • Stepan Company: Upside Unclear, Better Alternatives Exist

  • 3 Dividend Kings That Have Raised Payouts for 50+ Years and Still Look Cheap

  • Stepan (NYSE:SCL) Shares Gap Down After Earnings Miss

  • Stepan Company (SCL) Q4 2025 Earnings Call Transcript

  • Stepan Co. (SCL) Reports Q4 Loss, Misses Revenue Estimates

  • Stepan Reports Fourth Quarter and Full Year 2025 Results

  • Stepan Company Announces $100 Million Pre-Tax Cost Out and Efficiency Plan to Support Global Operations Optimization

  • Stepan Declares Quarterly Dividend

  • Dividend Kings: No Ideal Buys In February's 57

  • Tokuyama (OTCMKTS:TKYMY) versus Stepan (NYSE:SCL) Head to Head Comparison